Ceftazidime & Avibactam Injection 2.5g | Zavicefta - Pfizer

Advanced Dual-Action Intravenous Antibiotic

When managing severe, complicated, or highly multidrug-resistant Gram-negative bacterial infections, healthcare providers require an aggressive and highly sophisticated clinical intervention. The Ceftazidime 2gm / Avibactam 0.5gm powder for concentrate for solution for infusion (commercially recognized as Zavicefta) provides a potent, targeted antibiotic therapy designed strictly for intravenous (I.V.) administration. Manufactured by Pfizer, a globally renowned leader in critical care pharmaceuticals, this sterile formulation ensures the steady clinical performance necessary for acute care and intensive recovery protocols.

Why Choose Zavicefta for Critical Infection Management?

Tackling multidrug-resistant pathogens—such as those causing complicated intra-abdominal infections (cIAI), complicated urinary tract infections (cUTI), or hospital-acquired pneumonia (HAP)—requires a synergistic approach. Instead of relying on a single agent that beta-lactamase-producing bacteria may easily bypass, clinical specialists benefit from Zavicefta’s dual-action formulation. Ceftazidime (a cephalosporin) aggressively disrupts bacterial cell wall synthesis to halt growth. Simultaneously, Avibactam acts as a powerful non-beta-lactam beta-lactamase inhibitor, effectively shielding the Ceftazidime from destructive bacterial enzymes. This restores the antibiotic's efficacy against incredibly stubborn pathogens.

Key Product Specifications & Clinical Benefits

Potent Dual-Action Formula: Each vial contains a robust combination of Ceftazidime (2 gm) and Avibactam (0.5 gm), delivering a highly concentrated antibiotic dose for infusion.

Sterile Powder Format: Supplied as a sterile powder for concentrate, ensuring absolute maximum stability and potency of the active ingredients until the exact moment of clinical reconstitution.

Targeted Intravenous Delivery: Formulated strictly for Intravenous (I.V.) infusion, guaranteeing immediate systemic bioavailability for a rapid therapeutic response in acute hospital settings.

Clinical Supply: Conveniently packaged in a 10-vial box, providing an efficient supply for established hospital treatment protocols.

Essential Storage & Usage Guidelines

Maintaining the integrity of this critical care medication is vital for its clinical efficacy. Store the un-reconstituted vials at a temperature below 30°C. Protect strictly from light. Ensure that strict aseptic techniques are followed during reconstitution and dilution for infusion.

Important Notice: Zavicefta is a Prescription Drug. It must be prescribed, prepared, and administered strictly by a Registered Medical Practitioner in a clinical or hospital setting. Keep all medicines safely out of the reach of children.